Title: Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20120901
Title: Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.
Journal: International journal of clinical oncology 20120601
Title: A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.
Journal: European journal of cancer (Oxford, England : 1990) 20120101
Title: Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer.
Journal: World journal of surgical oncology 20120101
Title: Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature.
Journal: Cancer investigation 20120101
Title: Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience.
Journal: BMC urology 20120101
Title: Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial.
Journal: BJU international 20111201
Title: The use of estramustine phosphate in the modern management of advanced prostate cancer.
Journal: BJU international 20111201
Title: Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials.
Journal: Journal of cancer research and clinical oncology 20111201
Title: [Oral antineoplastic agents for prostate cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20110601
Title: Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032.
Journal: Urology 20110501
Title: Role of androgen deprivation treatment in patients with castration-resistant prostate cancer, receiving docetaxel-based chemotherapy.
Journal: American journal of clinical oncology 20110401
Title: A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.
Journal: The Prostate 20110401
Title: [Long-term disease stabilization by docetaxel plus estramustine for castration-resistant prostate cancer : report of a case].
Journal: Hinyokika kiyo. Acta urologica Japonica 20110401
Title: [A case of castration-refractory prostate cancer showing marked decrease of serum PSA level after zoledronic acid treatment with estramustine phosphate and prednisolone].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20110301
Title: A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006.
Journal: Cancer 20110201
Title: Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
Journal: Bioorganic & medicinal chemistry letters 20110115
Title: Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
Journal: Urologic oncology 20110101
Title: Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101
Title: A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer.
Journal: Anti-cancer drugs 20101101
Title: Cabazitaxel in prostate cancer: stretching a string.
Journal: Lancet (London, England) 20101002
Title: [Two cases of pellagra associated with chemotherapy of docetaxel, estramustine, dexamethasone].
Journal: Hinyokika kiyo. Acta urologica Japonica 20101001
Title: A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
Journal: Cancer immunology, immunotherapy : CII 20100701
Title: Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients.
Journal: International journal of urology : official journal of the Japanese Urological Association 20100701
Title: [Effect of the 5-HT3 receptor antagonist granisetron on estramustine phosphate sodium (Estracyt)-induced emesis in ferrets].
Journal: Hinyokika kiyo. Acta urologica Japonica 20100701
Title: Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100601
Title: [Prognostic factors for estrogen therapy of relapsed prostate cancer after maximal androgen blockade (MAB)].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20100501
Title: Hormonal therapy for prostate cancer: current topics and future perspectives.
Journal: International journal of urology : official journal of the Japanese Urological Association 20100401
Title: [Low-dose docetaxel, estramustine and dexamethasone combination chemotherapy for hormone-refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20100401
Title: Phase II study of vinorelbine and estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer.
Journal: International journal of radiation oncology, biology, physics 20100315
Title: Neoadjuvant LHRH analog plus estramustine phosphate combined with three-dimensional conformal radiotherapy for intermediate- to high-risk prostate cancer: a randomized study.
Journal: International urology and nephrology 20100301
Title: Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone.
Journal: Urologic oncology 20100101
Title: Final report on low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer.
Journal: Aktuelle Urologie 20100101
Title: [Chemotherapy with low-dose docetaxel and estramustine phosphate in patient with liver dysfunction due to liver metastases of hormone-refractory prostate cancer : a case report].
Journal: Hinyokika kiyo. Acta urologica Japonica 20100101
Title: [Update on the use of estramustin in metastatic prostate cancer].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20100101
Title: A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899.
Journal: Journal of translational medicine 20100101
Title: [11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months.
Journal: Tumori 20100101
Title: Single nucleotide polymorphisms of 17beta-hydroxysteroid dehydrogenase type 7 gene: mechanism of estramustine-related adverse reactions?
Journal: International journal of urology : official journal of the Japanese Urological Association 20091001
Title: Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association 20090801
Title: A phase I/II trial of fixed-dose docetaxel plus irinotecan and escalating doses of estramustine phosphate for second-line or greater treatment of selected advanced solid tumors.
Journal: Anti-cancer drugs 20090701
Title: Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090520
Title: [Toxicity and efficacy of intermittent docetaxel chemotherapy for hormone refractory prostate cancer].
Journal: Aktuelle Urologie 20090501
Title: Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients.
Journal: International journal of clinical oncology 20090401
Title: Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
Journal: International journal of radiation oncology, biology, physics 20090301
Title: Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20090301
Title: Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090301
Title: Combining docetaxel with estramustine: back to the future?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090301
Title: Change in markers of bone metabolism with chemotherapy for advanced prostate cancer: interleukin-6 response is a potential early indicator of response to therapy.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20090201
Title: Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience.
Journal: Anticancer research 20090201
Title: Paclitaxel, estramustine and carboplatin combination chemotherapy after initial docetaxel-based chemotherapy in castration-resistant prostate cancer.
Journal: Oncology 20090101
Title: Advantages of second line estramustine for overall survival of hormone-refractory prostate cancer (HRPC) patients.
Journal: Asian Pacific journal of cancer prevention : APJCP 20090101
Title: Oral chemotherapy in hormone-refractory prostate carcinoma patients unwilling to be admitted to hospital.
Journal: Urologia internationalis 20090101
Title: Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081220
Title: Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
Journal: Cancer 20081201
Title: Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer.
Journal: BJU international 20081201
Title: Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
Journal: American journal of clinical oncology 20081201
Title: Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110
Title: Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.
Journal: BJU international 20081101
Title: A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.
Journal: Clinical genitourinary cancer 20080901
Title: Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
Journal: Cancer research 20080801
Title: The postchemotherapy PSA surge syndrome.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080701
Title: [Estramustine phosphate withdrawal syndrome in relapsed prostate cancer: two case reports].
Journal: Hinyokika kiyo. Acta urologica Japonica 20080601
Title: Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Journal: Journal of the National Cancer Institute 20080507
Title: [Chemotherapy for prostate cancer].
Journal: Presse medicale (Paris, France : 1983) 20080501
Title: Pilot trial of adjuvant paclitaxel plus estramustine in resected high-risk prostate cancer.
Journal: Urology 20080501
Title: Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model.
Journal: BJU international 20080401
Title: The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301
Title: Editorial comment on: prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.
Journal: European urology 20080201
Title: Editorial comment on: prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.
Journal: European urology 20080201
Title: Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.
Journal: European urology 20080201
Title: Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC).
Journal: Investigational new drugs 20080201
Title: Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer.
Journal: BJU international 20080201
Title: Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancer.
Journal: Urology 20080201
Title: Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer.
Journal: Cancer chemotherapy and pharmacology 20080101
Title: Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.
Journal: International urology and nephrology 20080101
Title: Long-term control or possible cure? Treatment of stage D2 prostate cancer under chemotherapy using cisplatin and estramustine phosphate followed by maximal androgen blockade.
Journal: International urology and nephrology 20080101
Title: Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients.
Journal: International journal of urology : official journal of the Japanese Urological Association 20080101
Title: Endobronchial metastasis from prostate cancer.
Journal: International urology and nephrology 20080101
Title: Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer.
Journal: British journal of cancer 20071217
Title: Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071210
Title: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Journal: Journal of the National Cancer Institute 20071107
Title: Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study.
Journal: British journal of cancer 20071105
Title: Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.
Journal: The Lancet. Oncology 20071101
Title: Estramustine in prostate cancer: new look at an old drug.
Journal: The Lancet. Oncology 20071101
Title: [Clinical study on poor PSA response to initial endocrine therapy with MAB or estrogenic drugs for treatment of prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20071101
Title: [Prostate cancer: future strategies for chemotherapy management].
Journal: Annales d'urologie 20071001
Title: Progression after docetaxel-based chemotherapy in androgen-independent prostate cancer.
Journal: BJU international 20070901
Title: Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
Journal: Nature clinical practice. Oncology 20070901
Title: Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer.
Journal: BJU international 20070801
Title: [Prostate cancer and chemotherapy].
Journal: Bulletin du cancer 20070701
Title: Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070601
Title: Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma.
Journal: Clinical genitourinary cancer 20070601
Title: A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer.
Journal: Clinical genitourinary cancer 20070601
Title: [Mediastinal lymph nodes during the course of a metastatic prostate cancer].
Journal: Actas urologicas espanolas 20070601
Title: Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer.
Journal: European urology 20070501
Title: Docetaxel and beyond.
Journal: European urology 20070501
Title: Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer.
Journal: BJU international 20070501
Title: Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070501
Title: [Optimal treatment for elderly high-risk prostate cancer patients].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20070301
Title: Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model.
Journal: Cancer chemotherapy and pharmacology 20070201
Title: Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.
Journal: Hinyokika kiyo. Acta urologica Japonica 20070201
Title: Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.
Journal: International journal of urology : official journal of the Japanese Urological Association 20070101
Title: Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients.
Journal: Anticancer research 20070101
Title: Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer.
Journal: Cancer journal (Sudbury, Mass.) 20070101
Title: Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment.
Journal: Oncology research 20070101
Title: Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth.
Journal: Acta oncologica (Stockholm, Sweden) 20070101
Title: Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061201
Title: Phase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer.
Journal: Clinical genitourinary cancer 20061201
Title: Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061015
Title: A randomized study of docetaxel and dexamethasone with low- or high-dose estramustine for patients with advanced hormone-refractory prostate cancer.
Journal: BJU international 20060901
Title: A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer.
Journal: Clinical genitourinary cancer 20060901
Title: Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancer.
Journal: Clinical genitourinary cancer 20060901
Title: [Treatment strategy for advanced prostate cancer with bone metastases].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20060801
Title: A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer.
Journal: International journal of clinical oncology 20060801
Title: High-grade astrocytoma treated concomitantly with estramustine and radiotherapy.
Journal: Journal of neuro-oncology 20060701
Title: Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.
Journal: Expert opinion on investigational drugs 20060701
Title: Dramatic decline in prostate-specific antigen by withdrawal of estramustine phosphate in hormone refractory prostate cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association 20060701
Title: Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060620
Title: Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate.
Journal: Cancer 20060615
Title: Current chemotherapeutic approaches for androgen-independent prostate cancer.
Journal: Current opinion in investigational drugs (London, England : 2000) 20060601
Title: Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer.
Journal: Cancer 20060501
Title: Changing perspectives of the role of chemotherapy in advanced prostate cancer.
Journal: The Urologic clinics of North America 20060501
Title: Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice.
Journal: Cancer biotherapy & radiopharmaceuticals 20060401
Title: Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Journal: Clinical genitourinary cancer 20060301
Title: Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancer.
Journal: Acta medica Okayama 20060201
Title: Doxetaxel: new indication. Prostate cancer: a few more weeks.
Journal: Prescrire international 20060201
Title: A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy.
Journal: Cancer 20060101
Title: Repeated massive tongue swelling due to the combined use of estramustine phosphate and angiotensin-converting enzyme inhibitor.
Journal: Journal of investigational allergology & clinical immunology 20060101
Title: Evaluation of lipophilins as determinants of tumor cell response to estramustine.
Journal: The Journal of pharmacology and experimental therapeutics 20051201
Title: Therapeutic options in androgen-independent prostate cancer: building on docetaxel.
Journal: BJU international 20051201
Title: The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
Journal: European urology 20051101
Title: Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancer.
Journal: Onkologie 20051101
Title: [Prostate cancer with penile metastasis: a case report].
Journal: Hinyokika kiyo. Acta urologica Japonica 20051101
Title: Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer.
Journal: International journal of clinical oncology 20051001
Title: High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study.
Journal: The Journal of urology 20050901
Title: Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.
Journal: Anti-cancer drugs 20050901
Title: Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancer.
Journal: Clinical prostate cancer 20050901
Title: Epothilones and the next generation of phase III trials for prostate cancer.
Journal: BJU international 20050801
Title: The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Journal: Urology 20050801
Title: In vitro cytotoxic effects of imatinib in combination with anticancer drugs in human prostate cancer cell lines.
Journal: The Prostate 20050601
Title: Future directions in the treatment of androgen-independent prostate cancer.
Journal: Urology 20050601
Title: An interdisciplinary approach to treating prostate cancer.
Journal: Urology 20050601
Title: Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520
Title: Update in the management of patients with hormone-refractory prostate cancer.
Journal: Current opinion in urology 20050501
Title: The current role of chemotherapy in metastatic hormone-refractory prostate cancer.
Journal: Urology 20050501
Title: [Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies].
Journal: Bulletin du cancer 20050501
Title: Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients.
Journal: The Prostate 20050401
Title: Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate.
Journal: European urology 20050401
Title: Synergistic inhibitory effect of high-intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma.
Journal: BJU international 20050401
Title: Which drug combination for hormone-refractory prostate cancer?
Journal: Expert opinion on pharmacotherapy 20050401
Title: [The place of estramustine in the treatment of prostate cancer].
Journal: Orvosi hetilap 20050320
Title: Sequential mitoxantrone/prednisone followed by docetaxel/estramustine in patients with hormone refractory metastatic prostate cancer: results of a phase II study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050301
Title: Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301
Title: Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells.
Journal: Molecular cancer therapeutics 20050301
Title: A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20050301
Title: [Chemotherapy for prostate cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20050201
Title: [Treatment of androgen-independent hormone refractory prostate cancer using docetaxel].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20050201
Title: Single-nucleotide polymorphisms in the 17beta-hydroxysteroid dehydrogenase genes might predict the risk of side-effects of estramustine phosphate sodium in prostate cancer patients.
Journal: International journal of urology : official journal of the Japanese Urological Association 20050201
Title: Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?
Journal: Nature clinical practice. Oncology 20050201
Title: Chemotherapy for advanced prostate cancer.
Journal: The New England journal of medicine 20050113
Title: Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Journal: Urology 20050101
Title: A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050101
Title: Combination chemotherapy with docetaxel, estramustine and suramin for hormone refractory prostate cancer.
Journal: Urologic oncology 20050101
Title: Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines.
Journal: Urologic oncology 20050101
Title: Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
Journal: Urologic oncology 20050101
Title: Administration of estramustine in response to changes in the prostate-specific antigen and Karnofsky index in the treatment of prostate cancer.
Journal: In vivo (Athens, Greece) 20050101
Title: Prospective study of estramustine phosphate for hormone refractory prostate cancer patients following androgen deprivation therapy.
Journal: Urologia internationalis 20050101
Title: Radiation sensitizing effect of estramustine is not dependent on apoptosis.
Journal: Anticancer research 20050101
Title: Advances in prostate cancer chemotherapy: a new era begins.
Journal: CA: a cancer journal for clinicians 20050101
Title: Dose-finding study of weekly docetaxel plus estramustine in patients with hormone-refractory metastatic prostate cancer.
Journal: Tumori 20050101
Title: Docetaxel, estramustine and prednisone for hormone-refractory prostate cancer: a single-center experience.
Journal: Anticancer research 20050101
Title: Thromboembolic events with estramustine phosphate-based chemotherapy in patients with hormone-refractory prostate carcinoma: results of a meta-analysis.
Journal: Cancer 20041215
Title: Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma.
Journal: American journal of clinical oncology 20041201
Title: Long-term response to combination therapy with estramustine and somatostatin analogue in a patient with androgen ablation-refractory prostate cancer.
Journal: Urology 20041201
Title: Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.
Journal: Cancer 20041101
Title: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
Journal: The New England journal of medicine 20041007
Title: Is there a role for chemotherapy in prostate cancer?
Journal: British journal of cancer 20040913
Title: Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer.
Journal: Clinical prostate cancer 20040901
Title: [A clinical study of estramustine phosphate sodium for the treatment of hot flushes in men with prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20040901
Title: [Combination therapy with estramustine and docetaxel for hormone refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20040801
Title: Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.
Journal: Urology 20040701
Title: Gene expression profiling reveals novel targets of estramustine phosphate in prostate cancer cells.
Journal: Cancer letters 20040625
Title: Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.
Journal: The Prostate 20040615
Title: Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy.
Journal: International journal of oncology 20040601
Title: Simultaneous determination of estramustine phosphate and its four metabolites in human plasma by liquid chromatography-ionspray mass spectrometry.
Journal: Biomedical chromatography : BMC 20040601
Title: [Chemotherapy of the hormone-refractory prostate cancer].
Journal: Aktuelle Urologie 20040601
Title: Identification of a novel first exon of the human ABCA2 transporter gene encoding a unique N-terminus.
Journal: Biochimica et biophysica acta 20040416
Title: Weekly administration of docetaxel in patients with hormone-refractory prostate cancer: a pilot study on Japanese patients.
Journal: Japanese journal of clinical oncology 20040301
Title: Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma.
Journal: Cancer 20040215
Title: Chemohormonal therapy as primary treatment for metastatic prostate cancer: a randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist.
Journal: International journal of urology : official journal of the Japanese Urological Association 20040201
Title: [Docetaxel and prostate cancer].
Journal: Bulletin du cancer 20040201
Title: [Potentiation of focal ultrasound treatment of prostate adenocarcinoma by concomitant chemotherapy with estramustine phosphate and paclitaxel].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20040201
Title: Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer.
Journal: British journal of cancer 20040112
Title: Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study.
Journal: Urology 20040101
Title: Phase II trial of vinorelbine and estramustine in the treatment of metastatic hormone-resistant prostate cancer.
Journal: Urologic oncology 20040101
Title: Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma.
Journal: Journal of neuro-oncology 20040101
Title: High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer.
Journal: Anticancer research 20040101
Title: Treatment options in hormone-refractory metastatic prostate carcinoma.
Journal: Tumori 20040101
Title: Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
Journal: Urology 20031229
Title: Novel approaches to treating the asymptomatic hormone-refractory prostate cancer patient.
Journal: Urology 20031229
Title: A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.
Journal: Cancer 20031215
Title: The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancer.
Journal: The Journal of urology 20031201
Title: [Significance of docetaxel in the chemotherapy of hormone-refractory prostate cancer].
Journal: Onkologie 20031201
Title: [Intermittent oral hormonal chemotherapy using estramustine phosphate and etoposide for the treatment of hormone-refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20031201
Title: Combination chemotherapy for hormone-refractory prostate carcinoma: progress and pitfalls.
Journal: Cancer 20031115
Title: Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
Journal: Cancer 20031115
Title: Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.
Journal: Cancer 20031101
Title: Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.
Journal: Cancer 20031101
Title: Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20031001
Title: What next after hormonotherapy in cancer prostate?
Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20031001
Title: Prostate cancer and bone metastases: medical treatment.
Journal: Clinical orthopaedics and related research 20031001
Title: Weekly paclitaxel plus estramustine combination therapy in hormone-refractory prostate cancer: a pilot study.
Journal: International journal of urology : official journal of the Japanese Urological Association 20030901
Title: Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs.
Journal: International journal of pharmaceutics 20030811
Title: Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.
Journal: Cancer 20030715
Title: Chemotherapy of prostate cancer: present and future.
Journal: Current urology reports 20030601
Title: [Malignant priapism as a sign of a recurrent prostate cancer. Differential diagnosis of induratio penis plastica].
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20030601
Title: Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030601
Title: The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Journal: Urology 20030601
Title: Activity of docetaxel with or without estramustine phosphate versus mitoxantrone in androgen dependent and independent human prostate cancer xenografts.
Journal: The Journal of urology 20030501
Title: Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer.
Journal: Urology 20030401
Title: [Prostatic cancer in the young adult].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20030401
Title: Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030301
Title: Current studies with docetaxel in hormone-refractory prostate cancer: selected presentations from the 27th European Society for Medical Oncology Congress, 2002.
Journal: Clinical prostate cancer 20030301
Title: A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma.
Journal: Cancer 20030201
Title: Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
Journal: The Journal of urology 20030101
Title: A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting.
Journal: Anti-cancer drugs 20030101
Title: Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial.
Journal: Urology 20030101
Title: High-risk localized prostate cancer: primary surgery and adjuvant therapy.
Journal: Urologic oncology 20030101
Title: Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints.
Journal: Urologic oncology 20030101
Title: Hormone refractory advanced prostate cancer treated with estramustine and paclitaxel combination.
Journal: Anticancer research 20030101
Title: Combination chemotherapy with paclitaxel, estramustine and carboplatin for hormone refractory prostate cancer.
Journal: The Journal of urology 20021201
Title: Editorial: States and state transitions are all that really matter.
Journal: The Journal of urology 20021201
Title: An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancer.
Journal: Urology 20021201
Title: Fatal respiratory failure associated with treatment of prostate cancer using docetaxel and estramustine.
Journal: Urology 20021201
Title: [Chemotherapy for prostate cancers].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20021201
Title: [Therapy for hormone-refractory prostate cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20021201
Title: Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology 20021101
Title: [Hormonal chemotherapy for hormone-refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20021101
Title: Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20021001
Title: Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Journal: Urological research 20021001
Title: Penile metastasis of prostatic adenocarcinoma.
Journal: International journal of urology : official journal of the Japanese Urological Association 20021001
Title: Chemotherapy for prostate cancer.
Journal: Urology 20020901
Title: Hypertriglyceridemia and pancreatitis associated with estramustine phosphate.
Journal: American journal of clinical oncology 20020801
Title: Editorial: the coming revolution in the treatment of prostate cancer patients.
Journal: Seminars in urologic oncology 20020801
Title: Chemotherapy for androgen-independent prostate cancer.
Journal: Seminars in urologic oncology 20020801
Title: Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate.
Journal: Journal of cancer research and clinical oncology 20020801
Title: [Second cancer after starting treatment for prostate cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20020801
Title: Acute estramustine-induced hypocalcemia unmasking severe vitamin D deficiency.
Journal: The American journal of medicine 20020601
Title: The role of chemotherapy in advanced prostate cancer.
Journal: The Canadian journal of urology 20020601
Title: Estramustine phosphate combined with orchidectomy as first-line therapy in patients with prostate carcinoma. Effect of age on survival.
Journal: Cancer 20020515
Title: Estramustine phosphate enhances the effects of hyperthermia and induces the small heat shock protein HSP27 in the human prostate carcinoma cell line PC-3.
Journal: Urological research 20020501
Title: A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone.
Journal: Cancer 20020315
Title: Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma.
Journal: Cancer 20020301
Title: A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20020301
Title: Phase I clinical and pharmacologic trial of intravenous estramustine phosphate.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020215
Title: The flare in alkaline phosphatase activity post-orchidectomy predicts which patient may benefit from early chemotherapy in metastatic prostate cancer.
Journal: The Prostate 20020201
Title: EMP combination chemotherapy and low-dose monotherapy in advanced prostate cancer.
Journal: Expert review of anticancer therapy 20020201
Title: In vitro and in vivo activity of LS 4477 and LS 4559, novel analogues of the tubulin binder estramustine.
Journal: European journal of cancer (Oxford, England : 1990) 20020101
Title: Controversies in chemotherapy of prostate cancer.
Journal: Frontiers of radiation therapy and oncology 20020101
Title: The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.
Journal: Journal of neuro-oncology 20020101
Title: Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer.
Journal: Cancer investigation 20020101
Title: Estramustine plus a taxane for advanced prostate cancer: the new standard therapy?
Journal: Cancer investigation 20020101
Title: Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements.
Journal: Acta oncologica (Stockholm, Sweden) 20020101
Title: [Clinical efficacy of leuprolide acetate and combined treatment with estramustine for advanced prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20011101
Title: [A male case of primary bilateral breast cancers during estrogen therapy for prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20011101
Title: Combination therapy in hormone-refractory prostate cancer.
Journal: Current oncology reports 20010901
Title: Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
Journal: British journal of cancer 20010901
Title: Single-agent estramustine phosphate (EMP) is active in advanced breast cancer after failure with anthracyclines and taxanes.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20010901
Title: Secondary myelodysplastic syndrome after treatment of prostate cancer with oral estramustine.
Journal: American journal of hematology 20010801
Title: Treatment of hormone refractory prostate cancer.
Journal: Seminars in urologic oncology 20010801
Title: Can chemotherapy alter the course of prostate cancer?
Journal: Seminars in urologic oncology 20010801
Title: Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer.
Journal: Seminars in oncology 20010801
Title: Docetaxel, estramustine, and short-term androgen withdrawal for patients with biochemical failure after definitive local therapy for prostate cancer.
Journal: Seminars in oncology 20010801
Title: Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.
Journal: Seminars in oncology 20010801
Title: Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2.
Journal: Journal of neuro-oncology 20010801
Title: Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer.
Journal: Urology 20010701
Title: Estramustine-related hypocalcemia in patients with prostate carcinoma and osteoblastic metastases.
Journal: Urology 20010701
Title: A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma.
Journal: Cancer 20010601
Title: Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposide.
Journal: Cancer 20010601
Title: Paclitaxel and docetaxel in prostate cancer.
Journal: Hematology/oncology clinics of North America 20010601
Title: Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501
Title: Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport.
Journal: Pharmacology & toxicology 20010501
Title: Estramustine potentiates taxane in prostate and refractory breast cancers.
Journal: Oncology (Williston Park, N.Y.) 20010501
Title: The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20010501
Title: Distribution of estramustine-binding protein during postnatal development of rat brain.
Journal: Histochemistry and cell biology 20010501
Title: Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2).
Journal: Cancer research 20010415
Title: Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary results.
Journal: International journal of radiation oncology, biology, physics 20010301
Title: A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).
Journal: The Prostate 20010301
Title: The bleb formation of the extracellular pseudopodia; early evidence of microtubule depolymerization by estramustine phosphate in glioma cell; in vitro study.
Journal: Journal of neuro-oncology 20010301
Title: The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.
Journal: Cancer 20010215
Title: Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.
Journal: Urology 20010201
Title: Current status of cytotoxic chemotherapy in hormone refractory prostate cancer.
Journal: European urology 20010201
Title: Necessity of re-evaluation of estramustine phosphate sodium (EMP) as a treatment option for first-line monotherapy in advanced prostate cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association 20010201
Title: Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010101
Title: Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer.
Journal: Oncology 20010101
Title: Oral estramustine therapy in serum chromogranin A-positive stage D3 prostate cancer patients.
Journal: Anticancer research 20010101
Title: Treatment options in hormone-refractory prostate cancer: current and future approaches.
Journal: Drugs 20010101
Title: The treatment challenge of hormone-refractory prostate cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center 20010101
Title: [Chemotherapy of prostate cancer: potential role of docetaxel].
Journal: Tumori 20010101
Title: Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
Journal: Biochemical pharmacology 19980501
Title: Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer.
Journal: American journal of clinical oncology 19970801
Title: Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
Journal: British journal of cancer 19970101
Title: A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Journal: The Journal of urology 19860901
Title: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762.
Journal: The Journal of urology 19860201
Title: Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study.
Journal: Scandinavian journal of urology and nephrology 19860101
Title: Cooperative clinical trials of the National Prostatic Cancer Project: Protocol 900.
Journal: The Prostate 19840101
Title: Stricture of the anterior urethra following estrogen therapy in patients with prostatic cancer.
Journal: Urologia internationalis 19830101
Title: Cardiovascular complications in the treatment of prostatic carcinoma.
Journal: British journal of urology 19811201
Title: Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
Journal: Scandinavian journal of urology and nephrology. Supplementum 19800101
